- Why would a policy of re-importation of prescription drugs be ineffective?
- What are “orphan” drugs, and why are drug firms less likely to develop such drugs today?
- What is the consequence of the FDA providing the public with greater assurance that a new drug is safe?
- What methods have managed care plans used to limit their enrollees’ drug costs?
0 comments:
Post a Comment